$CYCC
Cyclacel Pharmaceuticals, Inc. Stock $cycc

$cycc Overview Financials Valuation SEC Filings Company Website

2011 Form 10-K Financial Statement

#000110465912022840 Filed on March 30, 2012

Income Statement

Concept	2011	2010 Q4	2010
Revenue	$699.0K	$140.0K	$112.0K
YoY Change	524.11%	-26.32%	-87.71%
Cost Of Revenue	$360.0K	$110.0K	$418.0K
YoY Change	-13.88%	57.14%	-23.3%
Gross Profit	$339.0K	$30.00K	-$306.0K
YoY Change	-210.78%	-72.73%	-183.61%
Gross Profit Margin	48.5%	21.43%	-273.21%
Selling, General & Admin	$6.542M	$2.020M	$8.833M
YoY Change	-25.94%	9.78%	3.46%
% of Gross Profit	1929.79%	6733.33%
Research & Development	$9.206M	$1.450M	$6.414M
YoY Change	43.53%	-44.02%	-34.32%
% of Gross Profit	2715.63%	4833.33%
Depreciation & Amortization	$241.0K	$110.0K	$457.0K
YoY Change	-47.26%	-35.29%	-31.59%
% of Gross Profit	71.09%	366.67%
Operating Expenses	$15.75M	$3.460M	$15.25M
YoY Change	3.29%	-21.9%	-16.7%
Operating Profit	-$15.75M	-$3.430M	-$15.14M
YoY Change	4.05%	-20.6%	-17.31%
Interest Expense	-$30.00K	$10.00K	$43.00K
YoY Change	-169.77%	-133.33%	-75.71%
% of Operating Profit
Other Income/Expense, Net	$580.0K	$110.0K	-$412.0K
YoY Change	-240.78%	-173.33%	-81.39%
Pretax Income	$904.0K	-$3.330M	-$3.533M
YoY Change	-125.59%	-25.84%	-82.78%
Income Tax	-$565.0K	-$150.0K	-$657.0K
% Of Pretax Income	-62.5%
Net Earnings	-$15.24M	-$3.170M	-$16.02M
YoY Change	-4.86%	-26.96%	-18.13%
Net Earnings / Revenue	-2180.69%	-2264.29%	-14304.46%
Basic Earnings Per Share
Diluted Earnings Per Share	-$42.33M	-$105.7M	-$801.0M
COMMON SHARES
Basic Shares Outstanding	7.186M shares		5.406M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2011	2010 Q4	2010
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.45M	$29.50M	$29.50M
YoY Change	-17.12%	156.74%	156.74%
Cash & Equivalents		$29.50M
Short-Term Investments	$19.89M		$29.07M
Other Short-Term Assets	$840.0K	$620.0K	$730.0K
YoY Change	15.07%	-64.16%	14.06%
Inventory		$170.0K	$170.0K
Prepaid Expenses
Receivables		$100.0K
Other Receivables		$660.0K
Total Short-Term Assets	$25.83M	$31.05M	$31.05M
YoY Change	-16.81%	132.24%	132.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$170.0K	$167.0K	$410.0K
YoY Change	-58.54%	-81.44%	-54.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00		$0.00
YoY Change			-100.0%
Total Long-Term Assets	$170.0K	$408.0K	$410.0K
YoY Change	-58.54%	-62.91%	-62.73%
TOTAL ASSETS
Total Short-Term Assets	$25.83M	$31.05M	$31.05M
Total Long-Term Assets	$170.0K	$408.0K	$410.0K
Total Assets	$26.00M	$31.46M	$31.46M
YoY Change	-17.36%	117.41%	117.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.720M	$1.723M	$1.720M
YoY Change	0.0%	0.76%	0.58%
Accrued Expenses	$3.700M	$4.132M	$2.930M
YoY Change	26.28%	-0.19%	-29.23%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.500M	$6.535M	$6.540M
YoY Change	-0.61%	-23.92%	-23.86%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.500M	$6.535M	$6.540M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$6.500M	$6.535M	$6.540M
YoY Change	-0.61%	-23.92%	-23.86%
SHAREHOLDERS EQUITY
Retained Earnings		-$241.8M
YoY Change
Common Stock		$47.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$19.50M	$24.92M	$24.92M
YoY Change
Total Liabilities & Shareholders Equity	$26.00M	$31.46M	$31.46M
YoY Change	-17.36%	117.41%	117.42%

Cashflow Statement

Concept	2011	2010 Q4	2010
OPERATING ACTIVITIES
Net Income	-$15.24M	-$3.170M	-$16.02M
YoY Change	-4.86%	-26.96%	-18.13%
Depreciation, Depletion And Amortization	$241.0K	$110.0K	$457.0K
YoY Change	-47.26%	-35.29%	-31.59%
Cash From Operating Activities	-$13.98M	-$3.740M	-$16.04M
YoY Change	-12.84%	64.76%	7.72%
INVESTING ACTIVITIES
Capital Expenditures	$6.000K	$0.00	$8.000K
YoY Change	-25.0%	-100.0%	-46.67%
Acquisitions
YoY Change
Other Investing Activities	$10.00K	$0.00	$40.00K
YoY Change	-75.0%	-100.0%	-97.45%
Cash From Investing Activities	$0.00	$0.00	$30.00K
YoY Change	-100.0%	-100.0%	-98.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$9.267M		$2.576M
YoY Change	259.74%		-33.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	8.910M	14.12M	33.40M
YoY Change	-73.32%	1326.26%	840.85%
NET CHANGE
Cash From Operating Activities	-13.98M	-3.740M	-16.04M
Cash From Investing Activities	0.000	0.000	30.00K
Cash From Financing Activities	8.910M	14.12M	33.40M
Net Change In Cash	-5.070M	10.38M	17.39M
YoY Change	-129.15%	-950.82%	-277.81%
FREE CASH FLOW
Cash From Operating Activities	-$13.98M	-$3.740M	-$16.04M
Capital Expenditures	$6.000K	$0.00	$8.000K
Free Cash Flow	-$13.99M	-$3.740M	-$16.05M
YoY Change	-12.85%	65.49%	7.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	89487000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	185799000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1752000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	9769000	USD
	us-gaap	Revenue From Grants RevenueFromGrants	3648000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	3021000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	3100000	USD
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50301144	shares
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	24924000	USD
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15971000	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-15243000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-15808000	USD
CY2011	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	580000	USD
CY2011	us-gaap	Investment Income Interest InvestmentIncomeInterest	45000	USD
CY2011	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-74000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-16388000	USD
CY2011	us-gaap	Costs And Expenses CostsAndExpenses	17087000	USD
CY2011	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7521000	USD
CY2011	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9206000	USD
CY2011	us-gaap	Cost Of Goods Sold CostOfGoodsSold	360000	USD
CY2011	us-gaap	Sales Revenue Net SalesRevenueNet	699000	USD
CY2011	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	699000	USD
CY2010	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37844695	shares
CY2010	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19703000	USD
CY2010	us-gaap	Net Income Loss NetIncomeLoss	-16021000	USD
CY2010	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-16678000	USD
CY2010	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-412000	USD
CY2010	us-gaap	Investment Income Interest InvestmentIncomeInterest	37000	USD
CY2010	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-68000	USD
CY2010	us-gaap	Operating Income Loss OperatingIncomeLoss	-16266000	USD
CY2010	us-gaap	Costs And Expenses CostsAndExpenses	16952000	USD
CY2010	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10120000	USD
CY2010	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6414000	USD
CY2010	us-gaap	Cost Of Goods Sold CostOfGoodsSold	418000	USD
CY2010	us-gaap	Sales Revenue Net SalesRevenueNet	686000	USD
CY2010	us-gaap	Revenue From Grants RevenueFromGrants	12000	USD
CY2010	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	574000	USD
CY2010	us-gaap	License And Services Revenue LicenseAndServicesRevenue	100000	USD
CY2009	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22196840	shares
CY2009	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20798000	USD
CY2009	us-gaap	Net Income Loss NetIncomeLoss	-19570000	USD
CY2009	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-20518000	USD
CY2009	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2214000	USD
CY2009	us-gaap	Investment Income Interest InvestmentIncomeInterest	102000	USD
CY2009	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-144000	USD
CY2009	us-gaap	Operating Income Loss OperatingIncomeLoss	-18304000	USD
CY2009	us-gaap	Costs And Expenses CostsAndExpenses	19215000	USD
CY2009	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8538000	USD
CY2009	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9766000	USD
CY2009	us-gaap	Cost Of Goods Sold CostOfGoodsSold	545000	USD
CY2009	us-gaap	Sales Revenue Net SalesRevenueNet	911000	USD
CY2009	us-gaap	Revenue From Grants RevenueFromGrants	1000	USD
CY2009	cycc	Dividends Preferred Stocks DividendsPreferredStocks	1228000	USD
CY2010	cycc	Dividends Preferred Stocks DividendsPreferredStocks	167000	USD
CY2011	cycc	Dividends Preferred Stocks DividendsPreferredStocks	728000	USD
	cycc	Dividends Preferred Stocks DividendsPreferredStocks	3657000	USD
CY2010	cycc	Redeemable Preferred Stocks Dividends RedeemablePreferredStocksDividends	3515000	USD
	cycc	Redeemable Preferred Stocks Dividends RedeemablePreferredStocksDividends	3515000	USD
	cycc	Dividends On Preferred Ordinary Shares DividendsOnPreferredOrdinaryShares	38123000	USD
	us-gaap	Accretion Expense AccretionExpense	100000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	3719000	USD
CY2010	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	30820000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	121678000	USD
CY2009	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3845000	USD
CY2010	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2576000	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9267000	USD
CY2009	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	910000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	91671000	USD
CY2009	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7000	USD
CY2011	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3000	USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2011Q4	cycc	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	13708505000	USD
CY2011Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1213142	shares
CY2011Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1213142	shares
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2010Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46564914	shares
CY2010Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46564914	shares
CY2010Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2010Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2010Q4	cycc	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	13344562000	USD
CY2010Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1213142	shares
CY2010Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1213142	shares
CY2010Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2010Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2010Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25998000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	19500000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-257064000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	57000	USD
CY2011Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	276452000	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	54000	USD
CY2011Q4	us-gaap	Preferred Stock Value PreferredStockValue	1000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	6498000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6498000	USD
CY2011Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	71000	USD
CY2011Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4664000	USD
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1763000	USD
CY2011Q4	us-gaap	Assets Assets	25998000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	167000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	25831000	USD
CY2011Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	182000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24449000	USD
CY2010Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31459000	USD
CY2010Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-241821000	USD
CY2010Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	31000	USD
CY2010Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	266666000	USD
CY2010Q4	us-gaap	Common Stock Value CommonStockValue	47000	USD
CY2010Q4	us-gaap	Preferred Stock Value PreferredStockValue	1000	USD
CY2010Q4	us-gaap	Liabilities Liabilities	6535000	USD
CY2010Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6535000	USD
CY2010Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	680000	USD
CY2010Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4132000	USD
CY2010Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1723000	USD
CY2010Q4	us-gaap	Assets Assets	31459000	USD
CY2010Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	408000	USD
CY2010Q4	us-gaap	Assets Current AssetsCurrent	31051000	USD
CY2010Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	174000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29495000	USD
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54220458	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54220458	shares
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2009	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-948000	USD
CY2010	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-657000	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-565000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-18444000	USD
CY2009	us-gaap	Interest Expense InterestExpense	177000	USD
CY2010	us-gaap	Interest Expense InterestExpense	43000	USD
	us-gaap	Interest Expense InterestExpense	4677000	USD
CY2009	cycc	Change In Valuation Of Warrants ChangeInValuationOfWarrants	299000	USD
CY2010	cycc	Change In Valuation Of Warrants ChangeInValuationOfWarrants	338000	USD
CY2011	cycc	Change In Valuation Of Warrants ChangeInValuationOfWarrants	-629000	USD
	cycc	Change In Valuation Of Warrants ChangeInValuationOfWarrants	-6699000	USD
CY2009	cycc	Payment Under Guarantee PaymentUnderGuarantee	1652000	USD
	cycc	Payment Under Guarantee PaymentUnderGuarantee	1652000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-298844000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-253549000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-271993000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5844000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	13725000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4329000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-328000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	-3550000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-277837000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	287606000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	173000	USD
CY2009	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	307000	USD
CY2011	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	364000	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	1898000	USD
CY2009	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	20000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	414000	USD
	us-gaap	Proceeds From Loans ProceedsFromLoans	9103000	USD
	cycc	Proceeds Of Committable Loan Notes Issued From Shareholders ProceedsOfCommittableLoanNotesIssuedFromShareholders	8883000	USD
	us-gaap	Loans And Leases Receivable Related Parties Collections LoansAndLeasesReceivableRelatedPartiesCollections	-1645000	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	17915000	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	-2297000	USD
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	1951000	USD
CY2008Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24220000	USD
CY2009Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11493000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-328000	USD
CY2009	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	59000	USD
CY2010	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	11000	USD
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	11746000	USD
CY2011	cycc	Change In Valuation Of Warrants Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities ChangeInValuationOfWarrantsAdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivities	-629000	USD
	cycc	Change In Valuation Of Warrants Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities ChangeInValuationOfWarrantsAdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivities	-6699000	USD
CY2009	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	668000	USD
CY2010	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	457000	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	241000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12555000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	886000	USD
CY2009	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	221000	USD
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	221000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-7747000	USD
	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	98000	USD
	cycc	Stock Option Plan Expenses StockOptionPlanExpenses	1215000	USD
CY2009	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-83000	USD
CY2010	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	13000	USD
CY2011	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-100000	USD
CY2009	us-gaap	Share Based Compensation ShareBasedCompensation	810000	USD
CY2010	us-gaap	Share Based Compensation ShareBasedCompensation	1746000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	882000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	19023000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	-1779000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2517000	USD
CY2009	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1716000	USD
CY2010	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-516000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-174000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	58000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	3763000	USD
CY2009	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15000	USD
CY2010	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8000	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8837000	USD
CY2009	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	91000	USD
CY2010	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	41000	USD
CY2011	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	5000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	163000	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	156657000	USD
CY2009	us-gaap	Accretion Expense AccretionExpense	2000	USD
CY2009	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	1483000	USD
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	162729000	USD
CY2011	dei	Entity Registrant Name EntityRegistrantName	Cyclacel Pharmaceuticals, Inc.
CY2011	dei	Entity Central Index Key EntityCentralIndexKey	0001130166
CY2011	dei	Document Type DocumentType	10-K
CY2011	dei	Document Period End Date DocumentPeriodEndDate	2011-12-31
CY2011	dei	Amendment Flag AmendmentFlag	false
CY2011	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2011	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2011	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2011	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2011	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2011Q2	dei	Entity Public Float EntityPublicFloat	63382642	USD
CY2012Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	59001738	shares
CY2011	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2011
CY2011	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY1999	us-gaap	Net Income Loss NetIncomeLoss	-3964000	USD
CY1999Q1	us-gaap	Stockholders Equity StockholdersEquity	-1538000	USD
CY2000	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	12717000	USD
CY2000	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	40000	USD
CY2000	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-194000	USD
CY2000	us-gaap	Net Income Loss NetIncomeLoss	-5686000	USD
CY2000Q1	us-gaap	Stockholders Equity StockholdersEquity	7983000	USD
CY2010	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	1082000	USD
	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	18207000	USD
CY2009	us-gaap	Interest Paid Net InterestPaidNet	-78000	USD
CY2009	cycc	Change In Valuation Of Warrants Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities ChangeInValuationOfWarrantsAdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivities	299000	USD
CY2010	us-gaap	Interest Paid Net InterestPaidNet	-155000	USD
	us-gaap	Interest Paid Net InterestPaidNet	-1914000	USD
	cycc	Acquisitions Of Equipment Purchased Through Capital Leases AcquisitionsOfEquipmentPurchasedThroughCapitalLeases	3470000	USD
	cycc	Issuance Of Ordinary Shares In Connection With License Agreements IssuanceOfOrdinarySharesInConnectionWithLicenseAgreements	592000	USD
	cycc	Issuance Of Ordinary Shares On Conversion Of Bridging Loan IssuanceOfOrdinarySharesOnConversionOfBridgingLoan	1638000	USD
CY2010	cycc	Change In Valuation Of Warrants Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities ChangeInValuationOfWarrantsAdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivities	338000	USD
	cycc	Issuance Of Preferred Ordinary Class C Shares On Conversion Of Secured Convertible Loan Notes And Accrued Interest IssuanceOfPreferredOrdinaryClassCSharesOnConversionOfSecuredConvertibleLoanNotesAndAccruedInterest	8893000	USD
	cycc	Issuance Of Ordinary Shares In Lieu Of Cash Bonus IssuanceOfOrdinarySharesInLieuOfCashBonus	164000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-4000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-290000	USD
CY1997Q1	us-gaap	Stockholders Equity StockholdersEquity	-293000	USD
CY1998	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4217000	USD
CY1998	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	55000	USD
CY1998	us-gaap	Net Income Loss NetIncomeLoss	-2534000	USD
CY1998Q1	us-gaap	Stockholders Equity StockholdersEquity	2009000	USD
CY1999	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	11000	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1746000	USD
CY2001	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-466000	USD
CY2001	us-gaap	Net Income Loss NetIncomeLoss	-10382000	USD
CY2001Q1	us-gaap	Stockholders Equity StockholdersEquity	-2590000	USD
CY2002	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	106000	USD
CY2002	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1215000	USD
CY2002	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	191000	USD
CY2002	us-gaap	Net Income Loss NetIncomeLoss	-14853000	USD
CY2002Q1	us-gaap	Stockholders Equity StockholdersEquity	-15076000	USD
CY2003	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12000	USD
CY2003	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1846000	USD
CY2003	us-gaap	Net Income Loss NetIncomeLoss	-15542000	USD
CY2003Q1	us-gaap	Stockholders Equity StockholdersEquity	-32147000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	27635000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	115000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	58148000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1343000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-14977000	USD
CY2003Q4	us-gaap	Stockholders Equity StockholdersEquity	37648000	USD
CY2004	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8541000	USD
CY2004	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-1918000	USD
CY2004	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2424000	USD
CY2004	us-gaap	Net Income Loss NetIncomeLoss	-22742000	USD
CY2004Q4	us-gaap	Stockholders Equity StockholdersEquity	23953000	USD
CY2005	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1786000	USD
CY2005	us-gaap	Net Income Loss NetIncomeLoss	-18048000	USD
CY2005Q4	us-gaap	Stockholders Equity StockholdersEquity	4119000	USD
CY2006	cycc	Adjustments To Additional Paid In Capital Loans Payable Waived AdjustmentsToAdditionalPaidInCapitalLoansPayableWaived	10420000	USD
CY2006	cycc	Stock And Warrants Issued During Period Value StockAndWarrantsIssuedDuringPeriodValue	42362000	USD
CY2006	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9600000	USD
CY2006	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	5000	USD
CY2006	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	416000	USD
CY2006	us-gaap	Net Income Loss NetIncomeLoss	-29258000	USD
CY2006Q4	us-gaap	Stockholders Equity StockholdersEquity	53919000	USD
CY2007	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1733000	USD
CY2007	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	163000	USD
CY2007	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	33357000	USD
CY2007	us-gaap	Dividends Preferred Stock DividendsPreferredStock	307000	USD
CY2007	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	-6750000	USD
CY2007	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-93000	USD
CY2007	us-gaap	Net Income Loss NetIncomeLoss	-24053000	USD
CY2007Q4	us-gaap	Stockholders Equity StockholdersEquity	57969000	USD
CY2008	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1698000	USD
CY2008	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1227000	USD
CY2008	cycc	Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTaxPortionAttributableToParent	-12330000	USD
CY2008	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	14918000	USD
CY2008	us-gaap	Net Income Loss NetIncomeLoss	-40386000	USD
CY2008Q4	us-gaap	Stockholders Equity StockholdersEquity	20642000	USD
CY2009	cycc	Adjustments To Additional Paid In Capital Effect Of Warrant Pricing AdjustmentsToAdditionalPaidInCapitalEffectOfWarrantPricing	44000	USD
CY2009	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2847000	USD
CY2009	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7000	USD
CY2009	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	810000	USD
CY2009	cycc	Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTaxPortionAttributableToParent	5651000	USD
CY2009	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-5589000	USD
CY2009Q4	us-gaap	Stockholders Equity StockholdersEquity	5872000	USD
CY2010	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11897000	USD
CY2010	cycc	Stock Issued During Period Value Private Placement StockIssuedDuringPeriodValuePrivatePlacement	13980000	USD
CY2010	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	77000	USD
CY2010	cycc	Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTaxPortionAttributableToParent	-2073000	USD
CY2010	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2084000	USD
CY2011	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9272000	USD
CY2011	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	882000	USD
CY2011	us-gaap	Dividends Preferred Stock DividendsPreferredStock	364000	USD
CY2011	cycc	Other Comprehensive Income Unrealized Foreign Exchange On Intercompany Loans Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeUnrealizedForeignExchangeOnIntercompanyLoansNetOfTaxPortionAttributableToParent	-622000	USD
CY2011	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	648000	USD
CY2011	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	685000	USD

Files In Submission

Name	View Source	Status
0001104659-12-022840-index-headers.html	Edgar Link	pending
0001104659-12-022840-index.html	Edgar Link	pending
0001104659-12-022840.txt	Edgar Link	pending
0001104659-12-022840-xbrl.zip	Edgar Link	pending
a12-2664_110k.htm	Edgar Link	pending
a12-2664_1ex21.htm	Edgar Link	pending
a12-2664_1ex23d1.htm	Edgar Link	pending
a12-2664_1ex23d2.htm	Edgar Link	pending
a12-2664_1ex31d1.htm	Edgar Link	pending
a12-2664_1ex31d2.htm	Edgar Link	pending
a12-2664_1ex32d1.htm	Edgar Link	pending
a12-2664_1ex32d2.htm	Edgar Link	pending
cycc-20111231.xml	Edgar Link	completed
cycc-20111231.xsd	Edgar Link	pending
cycc-20111231_cal.xml	Edgar Link	unprocessable
cycc-20111231_def.xml	Edgar Link	unprocessable
cycc-20111231_lab.xml	Edgar Link	unprocessable
cycc-20111231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CYCC
Cyclacel Pharmaceuticals, Inc. Stock $cycc

2011 Form 10-K Financial Statement

#000110465912022840 Filed on March 30, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYCC Cyclacel Pharmaceuticals, Inc. Stock $cycc

2011 Form 10-K Financial Statement

#000110465912022840 Filed on March 30, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CYCC
Cyclacel Pharmaceuticals, Inc. Stock $cycc